PHARMOS CORP
10-Q, EX-27, 2000-11-14
PHARMACEUTICAL PREPARATIONS
Previous: PHARMOS CORP, 10-Q, 2000-11-14
Next: SUN BANCORP INC, 10-Q, 2000-11-14



<TABLE> <S> <C>


<ARTICLE>    5


<S>                                 <C>

<PERIOD-TYPE>                       9-MOS
<FISCAL-YEAR-END>                             DEC-31-2000
<PERIOD-END>                                  SEP-30-2000
<CASH>                                         23,737,327
<SECURITIES>                                            0
<RECEIVABLES>                                   1,254,237
<ALLOWANCES>                                            0
<INVENTORY>                                     1,114,423
<CURRENT-ASSETS>                               26,521,720
<PP&E>                                          3,356,414
<DEPRECIATION>                                (1,920,470)
<TOTAL-ASSETS>                                 33,029,727
<CURRENT-LIABILITIES>                           2,652,749
<BONDS>                                                 0
<COMMON>                                        1,616,016
                                   0
                                             0
<OTHER-SE>                                     21,127,547
<TOTAL-LIABILITY-AND-EQUITY>                   33,029,727
<SALES>                                         3,740,152
<TOTAL-REVENUES>                                3,840,152
<CGS>                                           1,337,893
<TOTAL-COSTS>                                   7,076,891
<OTHER-EXPENSES>                                (736,975)
<LOSS-PROVISION>                                (736,975)
<INTEREST-EXPENSE>                                438,578
<INCOME-PRETAX>                               (4,276,235)
<INCOME-TAX>                                            0
<INCOME-CONTINUING>                           (4,276,235)
<DISCONTINUED>                                          0
<EXTRAORDINARY>                                         0
<CHANGES>                                               0
<NET-INCOME>                                  (4,276,235)
<EPS-BASIC>                                         (.08)
<EPS-DILUTED>                                       (.08)



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission